BA
REGN icon

Birinyi Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Birinyi Associates’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,075
Closed -$1.48M – 59
2024
Q4 		$1.48M Buy
+2,075
New +$1.74M 0.41% 28
2017
Q3 		– Sell
-500
Closed -$246K – 91
2017
Q2 		$246K Buy
+500
New +$219K 0.12% 85
2017
Q1 		– Sell
-1,000
Closed -$367K – 95
2016
Q4 		$367K Buy
1,000
+500
+100% +$190K 0.21% 67
2016
Q3 		$201K Buy
+500
New +$201K 0.11% 85
2016
Q2 		– Sell
-700
Closed -$252K – 81
2016
Q1 		$252K Sell
700
-500
-42% -$206K 0.11% 74
2015
Q4 		$651K Buy
1,200
+700
+140% +$379K 0.42% 54
2015
Q3 		$233K Buy
500
+50
+11% +$26.9K 0.1% 83
2015
Q2 		$230K Buy
+450
New +$220K 0.16% 78

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return